What findings are expected on a T2-weighted magnetic resonance imaging (MRI) scan?

T2-Weighted MRI: Expected Findings

T2-weighted MRI sequences display tissues with high water content as bright (hyperintense) signal, while tissues with low water content or bound water appear dark (hypointense), making them essential for detecting edema, inflammation, cystic lesions, and fluid collections across all anatomical regions.

Fundamental Signal Characteristics

T2-weighted imaging exploits the differential relaxation properties of tissues to create contrast. The key principle is that free water (such as cerebrospinal fluid, edema, or cystic fluid) appears bright, while bound water (such as in muscle, cartilage, or normal bone marrow) appears relatively dark 1.

Technical Requirements for Optimal T2-Weighting

To achieve proper T2-weighting, specific technical parameters are critical:

• Echo time (TE) must be sufficiently long: approximately 80+ ms for spin-echo sequences and 50+ ms for STIR sequences 1
• This longer TE weakens signal from bound water while preserving strong signal from free water
• Inadequate T2-weighting can lead to misinterpretation, particularly when evaluating inflammatory conditions

Anatomical Region-Specific Findings

Brain and Central Nervous System

T2-weighted sequences are the cornerstone for detecting white matter lesions, edema, and inflammatory processes in the brain 2:

• Lesion detection: White matter lesions appear hyperintense (bright) on T2-weighted images
• Recommended slice thickness: 3 mm with no interslice gap at 3T; up to 4 mm at 1.5T 2
• Echo train length: 8-16 for optimal balance between acquisition speed and image quality 2

T2-FLAIR (Fluid-Attenuated Inversion Recovery) is a specialized T2-weighted sequence that suppresses cerebrospinal fluid signal 2:

• Improves visualization of periventricular and juxtacortical lesions
• Better depicts vasogenic edema, gliosis, and infiltrating tumors near cortex and ventricles
• Less sensitive for infratentorial (posterior fossa) lesions compared to standard T2-weighted images 3

Musculoskeletal System (Sacroiliac Joints and Spine)

For inflammatory arthropathies, T2-weighted sequences with fat suppression are mandatory for detecting active inflammation 1:

Bone Marrow Edema (BME)

• Appears as ill-defined hyperintense signal on fat-suppressed T2-weighted images (STIR or T2-FS)
• Located in subchondral bone marrow adjacent to joints
• Indicates active inflammation when clearly present in typical anatomical locations 1

Capsulitis and Enthesitis

• Hyperintense signal on STIR or T2-FS sequences with associated soft tissue thickening
• Reflects active inflammation at capsular margins or tendon/ligament insertion sites 1

Spine Inflammatory Lesions

• Corner lesions: Triangular hyperintense areas at vertebral body corners on fluid-sensitive sequences
• Centered on entheses of annulus fibrosus or longitudinal ligaments 1

Whole-Body Imaging

For cancer screening and systemic disease evaluation 4:

• T2-weighted sequences (typically HASTE or STIR) detect lesions throughout the body
• STIR sequences provide uniform fat suppression over large fields of view
• Particularly useful for detecting bone marrow abnormalities and soft tissue lesions

Common Pitfalls and Caveats

Age-Related Considerations

Normal bone marrow composition varies with age, containing both fatty and erythropoietic marrow 1:

• Erythropoietic marrow may appear relatively bright on fat-suppressed sequences
• This can be mistaken for pathology if T2-weighting is inadequate
• Proper T2-weighting (long TE) resolves this by suppressing erythropoietic marrow signal while maintaining edema signal

Sequence Selection Matters

Not all T2-weighted sequences are equivalent 3, 5:

• Standard T2-weighted or proton-density sequences are the reference standard for most applications
• T2-FLAIR is less sensitive for posterior fossa lesions due to flow artifacts
• In areas prone to flow artifacts (posterior fossa, anterior temporal lobes), confirmation on both T2-FLAIR and standard T2-weighted images is required 3

Contrast Enhancement Timing

When combining T2-weighted imaging with contrast-enhanced studies 2:

• Acquire T2-weighted images AFTER contrast injection but before T1-weighted post-contrast images
• This standardizes timing and utilizes the 5-8 minute delay period efficiently
• T2-weighted spin-echo sequences are relatively insensitive to vascular contrast agent presence

Clinical Applications by Signal Intensity

Hyperintense (Bright) on T2-Weighted Images

Expected findings include:

• Free fluid (CSF, joint effusions, cysts)
• Edema (vasogenic, cytotoxic, bone marrow)
• Active inflammation
• Most tumors (due to increased water content)
• Mucus-containing lesions 6

Hypointense (Dark) on T2-Weighted Images

Expected findings include:

• Cortical bone
• Calcifications
• Hemosiderin deposits
• Fibrous tissue
• Muscle
• Normal cartilage
• Sclerotic bone 1

Integration with Other Sequences

T2-weighted imaging should never be interpreted in isolation:

• Combine with T1-weighted images to distinguish edema from fat, assess structural damage, and detect erosions 1
• Diffusion-weighted imaging (DWI) complements T2-weighted sequences for tumor characterization and acute ischemia detection 2
• T2-FLAIR enhances lesion conspicuity in specific anatomical locations 2

The interpretation of T2-weighted findings must always be correlated with clinical context, patient age, and complementary imaging sequences to avoid misdiagnosis.